THBS4 and bladder transitional cell carcinoma: Importantly, interventions targeting TSP4 or its interaction with integrin αvβ3 may hold translational potential, providing a strategy to inhibit lymphatic metastasis and potentially improve clinical outcomes for BLCA patients.